Before any clothing can be recycled, it must be taken apart. This process, known as disassembly, is quickly becoming a major sticking point in the race to scale textile-to-textile recycling. “You ...

C SL has broken ground for an expansion of its state-of-the-art manufacturing facility in Kankakee, Illinois. The newly expanded facility will substantially increase the global biopharma company’s ...

The Fanatec ClubSport GT Cockpit certainly looks the part, and the good news is that its feature set, ease of use and overall performance make it a really compelling rig option for sim racers, albeit ...

Exclusive licensing grants Lilly development and commercialization rights for clazakizumab beyond ESKD-related cardiovascular prevention, while CSL retains the ESKD cardiovascular events indication.

It's been a sad week for CSL Limited (ASX:CSL), who've watched their investment drop 16% to AU$152 in the week since the company reported its interim result. Revenues came in 2.7% below expectations, ...

CSL announced the exit of Paul McKenzie as chief executive. Senior executive Gordon Naylor appointed interim CEO. Shares of Australian biotech firm CSL plunged to an 8-year low Wednesday after it ...

Australian pharmaceuticals heavyweight CSL has announced its chief executive Dr Paul McKenzie is retiring with immediate effect, as the company tries to rebuild confidence among investors following a ...

CSL has gotten the Memo about the value of recombinant polyclonal immunoglobulin (IgG) antibodies. The company is signing on to a collaboration and option agreement with Memo Therapeutics that could ...

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. If you are wondering whether ...

CSL shares have dropped significantly in 2025, reaching a seven-year low, due to restructuring and downgraded growth prospects. The company’s core business is robust, with ongoing global demand and ...

CSL shares are dipping partly due to broader market weakness after Wall Street's recent selloff, and a downgrade from Macquarie lowering CSL's target price significantly, signalling concerns over its ...